First Trust Advisors LP Provention Bio, Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.66 - $8.33 $774,106 - $1.14 Million	-136,768 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.71 - $11.04 $33,113 - $54,482	-4,935 Reduced 3.48%	136,768 $1.15 Million
Q1 2021 May 14, 2021	BUY	$10.12 - $19.45 $258,434 - $496,694	25,537 Added 21.98%	141,703 $1.49 Million
Q4 2020 Feb 02, 2021	SELL	$11.79 - $18.94 $56,627 - $90,968	-4,803 Reduced 3.97%	116,166 $1.97 Million
Q3 2020 Nov 05, 2020	BUY	$10.34 - $15.2 $1.25 Million - $1.84 Million	120,969 New	120,969 $1.55 Million

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.